- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Hormone-Sensitive Prostate Cancer in United States
Total 8953 results
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Mexico, Belgium, Korea, Republic of, Turkey, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
Mamta ParikhNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States
-
Astellas Pharma Europe Ltd.Medivation, Inc.CompletedMetastatic Castration Resistant Prostate CancerCzechia, Netherlands, Denmark, Italy, Austria, Belgium, Bulgaria, France, Germany, Greece, Hungary, Ireland, Portugal, Slovenia, Spain, United Kingdom
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
Inmune Bio, Inc.RecruitingCancer | Metastatic Castration-resistant Prostate Cancer | mCRPCUnited States
-
Noxopharm LimitedTerminatedMetastatic Castration-resistant Prostate Cancer and Other Solid TumorsUnited States
-
Celcuity IncRecruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Genital Diseases, Male | Prostatic Disease | mCRPC (Metastatic Castration-resistant Prostate Cancer) | Urogenital Diseases, MaleUnited States, France, Spain, United Kingdom
-
Merrion Pharmaceuticals, LLCCompletedHormone-Refractory Prostate CancerUnited States, Estonia, Latvia
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
Weill Medical College of Cornell UniversityConvergent Therapeutics, Inc.WithdrawnProstate Cancer MetastaticUnited States
-
Cota Inc.Blue Cross Blue Shield; NantHealth Inc.TerminatedPancreatic Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Melanoma | Metastatic Prostate Cancer | Metastatic Colon CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Orion Corporation, Orion PharmaActive, not recruitingProstate Cancer MetastaticFrance, United Kingdom, Finland, United States
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City; Celldex Therapeutics and other collaboratorsCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Oncternal Therapeutics, IncRecruitingMetastatic Castration-resistant Prostate CancerUnited States, United Kingdom
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Rana McKay, MDBristol-Myers Squibb; ExelixisRecruitingMetastatic Cancer | Castration-resistant Prostate CancerUnited States
-
VA Office of Research and DevelopmentRecruitingRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Oligometastasis | Oligorecurrence | De Novo Prostate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Prostate Cancer Foundation; Madison Vaccines, IncRecruitingProstate Cancer | Metastatic Cancer | Castration-resistant Prostate CancerUnited States
-
Syntrix Biosystems, Inc.National Cancer Institute (NCI)Not yet recruitingMetastatic Castration-resistant Prostate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Swedish Medical CenterRecruitingProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
University of UtahNational Cancer Institute (NCI)RecruitingFatigue | Sedentary Lifestyle | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC (American Joint Committee on Cancer) v8 | Stage IVA Prostate Cancer AJCC (American Joint Committee on Cancer) v8 | Stage IVB Prostate Cancer AJCC (American Joint Committee on Cancer) v8United States
-
University College, LondonEpic SciencesRecruitingMetastatic Prostate CancerUnited Kingdom
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Institutes of Health (NIH)CompletedProstate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Fortis Therapeutics, Inc.CompletedProstate Cancer MetastaticUnited States
-
David M. Schuster, MDTerminatedProstate CancersUnited States
-
Thomas Jefferson UniversityProstate Cancer FoundationActive, not recruitingBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
Imperial College LondonProstate Cancer UK; Imperial Clinical Trials Unit (ICTU)RecruitingProstate Cancer | Prostate Adenocarcinoma | Non-metastatic Prostate CancerUnited Kingdom
-
AstraZenecaBayerRecruitingMetastatic Prostate CancerItaly, United Kingdom, Australia, United States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
AbbVieRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Israel
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma | Castration-Resistant...United States
-
UNC Lineberger Comprehensive Cancer CenterPatient-Centered Outcomes Research InstituteCompletedProstate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of ProstateUnited States
-
Bristol-Myers SquibbRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Tceleron Therapeutics, Inc.TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedStage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Hormone-refractory Prostate CancerUnited States
-
Novo Nordisk A/STerminated
-
University of Colorado, DenverEDAP TMS S.A.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
National Cancer Institute (NCI)CompletedStage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Prostate CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the ProstateUnited States